Skip to main content
. Author manuscript; available in PMC: 2016 Aug 1.
Published in final edited form as: Oral Oncol. 2016 Mar 16;56:17–24. doi: 10.1016/j.oraloncology.2016.02.010

Table 3.

Cox Proportional Hazards Model for Patient Overall Survival

Patient Characteristic Adjusted HR
(95% CI)
p value
   

Age at Diagnosis
Race
1.023 (1.02-1.03) <0.001

  Non-Hispanic White - -
  Non-Hispanic Black 1.55(1.39-1.72) <0.001
  Hispanic 0.87 (0.70-1.09) 0.23
  Other 0.88 (0.66-1.17) 0.37

Primary Tumor Site

  Base of Tongue - -
  Tonsil 1.00 (0.93-1.09) 0.92
  Pharyngeal Wall/ Soft Palate 1.70 (1.44-2.01) <0.001
  Oropharynx NOS 1.48 (1.29-1.70) <0.001

  Clinical Stage

  III - -
  IV 1.37 (1.26-1.50) <0.001

Comorbidity Index

  None - -
  Moderate (1) 1.49 (1.34-1.66) <0.001
  High (2) 1.47 (1.17-1.84) 0.001

Year of Diagnosis

  2003 - -
  2004 0.96 (0.86-1.07) 0.41
  2005 1.04 (0.93-1.15) 0.51
  2006 1.01 (0.90-1.13) 0.89

Radiation Technique

  Non-IMRT - -
  IMRT 0.75 (0.68-0.82) <0.001

Treatment Facility

  Community - -
  Academic 1.01 (0.93-1.10) 0.82

Facility Case-Volume

  Low Case-Volume - -
  High Case-Volume 0.84 (0.76-0.93) 0.001

Geographic Region

  Northeast - -
  Southeast 0.99 (0.89-1.11) 0.91
  Midwest 1.00 (0.90-1.11) 0.99
  West 0.87 (0.76-0.99) 0.04

Insurance Status

  Commercial Insurance - -
  Medicare 1.74 (1.56-1.94) <0.001
  Medicaid 2.10 (1.86-2.37) <0.001
  Uninsured 2.05 (1.79-2.36) <0.001
  Government 1.69 (1.32-2.16) <0.001
  Unknown 1.80 (1.42-2.27) <0.001

Diagnosis to Treatment Interval

DTI ≤ 30 days - -
DTI > 30 days 1.12 (1.03-1.20) 0.005
DTI (measured in weeks) 1.02 (1.01-1.03) <0.001
DTI in Tertiles
DTI ≤ 3 weeks - -
DTI 3-6 weeks 1.15 (1.05-1.27) 0.003
DTI > 6 weeks 1.22 (1.10-1.35) <0.001